Dispute Between Biopharma Cos. To Be Resolved by Sept. 30 - Streetwise Reports

Retrieved on: 2022-06-16 15:04:25

Tags for this article:

Finance

Money

Economy

Primary dealers

Subprime mortgage crisis

United States securities law

Financial analyst

Valuation

Investment banking

Financial Industry Regulatory Authority

UBS

Security

Edward White

TRACON Pharmaceuticals Inc

I-Mab

Click the tags to see associated articles and topics

Dispute Between Biopharma Cos. To Be Resolved by Sept. 30 - Streetwise Reports. View article details on HISWAI: https://www.streetwisereports.com/article/2022/06/16/dispute-between-biopharma-cos-to-be-resolved-by-sept-30.html

Excerpt

TRACON Pharmaceuticals Inc. (TCON:NASDAQ) just received word that the deadline for a decision in its ongoing arbitration with I-Mab Biopharma was ...

Article found on: www.streetwisereports.com

View Original Article